Life Science Leader Magazine Supplements

CMO 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 10 of 81

LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 9 arson may be indulging in a bit of introversion inflation. After all, her career included a suc- cessful climb through Genentech, starting as that shy associate engineer and then progress- ing to leadership roles, including global head of techni- cal development in business operations (Roche), before she moved to Achaogen last year. (And does that look like an introvert on our cover?) In one of my recent con- versations with Larson she says: "I used to be so cau- tious. Now it's time to be more open and provocative." Fortunately, we get both sides of Larson as she explores the real needs of drug sponsors today. She offers up thoughts like this: "It's interesting to think about why the small molecule industry, including CDMOs and CMOs, hasn't learned or revolutionized in the way the biologics industry has, even in places where we have common technology." And this: "If you can get 200 percent more out of a biologics manu- facturing process from a CMO, who cares? That's not what's driving our business decisions." s o M e s T r a i g h T T a l k T o c m o s Achaogen's Tina Larson opens up on the real business needs of sponsors I spent much of my career as an introverted engineer, only comfortable speaking to close colleagues and avoiding crowds. TINA LARSON VP of Technical Operations Achaogen L L O U I S G A R G U I L O Chief Editor, Outsourced Pharma @Louis_Garguilo

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2017